Bio-Techne (TECH) Q3 2026 Earnings
Bio-Techne reported Q3 2026 revenue of $311.4M (-1.5% YoY), missed analyst consensus of $316.1M by $4.7M. Diluted EPS came in at $0.53 (-5.4% YoY), missed the $0.55 consensus by $0.02.
Financial Snapshot
Trailing eight quarters through Q3 2026
Q3 2026 Earnings FAQ
Common questions about Bio-Techne's Q3 2026 earnings report.
Bio-Techne (TECH) reported Q3 2026 earnings on May 6, 2026 before market open.
Bio-Techne reported revenue of $311.4M and diluted EPS of $0.53 for Q3 2026.
Revenue missed the consensus estimate of $316.1M by $4.7M. EPS missed the consensus estimate of $0.55 by $0.02.
Compared to the same quarter a year prior, revenue declined 1.5% from $316.2M a year earlier and diluted EPS declined 5.4% from $0.56.
You can read the 8-K earnings release (0001104659-26-055887) and the 10-Q periodic report (0001104659-26-056302) directly on SEC EDGAR. The filing index links above go to sec.gov.